ModifiedUnitedHealthcarePolicy CS097LA.Q

Pneumatic Compression Devices (for Louisiana Only)

Defines UnitedHealthcare Louisiana medical policy governing coverage and medical necessity of pneumatic compression devices (PCDs), including advanced devices, for indications such as lymphedema, peripheral arterial disease (PAD), DVT prevention, and chronic venous insufficiency (CVI). Applies to providers and members in Louisiana.

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices (for Louisiana Only)

Policy CodePolicy CS097LA.Q

Change TypeCoding update — HCPCS list amended

Effective DateNov 1, 2025

Next Review Date

Key ActionUse the updated HCPCS code list (including newly added E0658 and E0659) when submitting prior authorization requests and claims.

SourceLink

POLICY UPDATE CHANGES

Updated list of applicable HCPCS codes to reflect quarterly edits; added E0658 and E0659.

LAstate

11/01/2025effective

CS097LA.Qpolicy id

E0650-E0676HCPCS range

E0658,E0659

Coverage Criteria

inv-01: Covered indications (subject to InterQual criteria)

Covered when InterQual clinical criteria are met for indicated conditions; specific mentions in the policy:

Covered indications summarized: Pneumatic compression devices are considered proven and medically necessary in certain circumstances for the treatment of lymphedema or chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers; intermittent limb compression devices are proven and medically necessary in certain circumstances for prevention of deep venous thrombosis (DVT). For medical necessity clinical coverage criteria, refer to the InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices.

See InterQual for specific clinical criteria and eligibility.

inv-02: Not medically necessary — APCDs for head/face/neck lymphedema

Not medically necessary: head/neck APCD: Advanced intermittent pneumatic compression devices (e.g., Flexitouch) for treating lymphedema of the head, face, or neck are considered unproven and not medically necessary.

Policy identifies these uses as not medically necessary.

inv-03: Not medically necessary — high-pressure devices for PAD

Not medically necessary — PAD high-pressure devices: Pneumatic compression devices (high pressure, rapid inflation/deflation cycle) for treating peripheral arterial disease (PAD) are considered unproven and not medically necessary.

Evidence for safety and efficacy of high-pressure devices in arterial insufficiency is insufficient.

inv-04: Coverage contexts supported by evidence and guideline statements

Select guideline recommendations and trial evidence supporting IPC use in specific clinical scenarios:

CLTI (chronic limb-threatening ischemia): AHA/ACC (2024) states arterial IPC devices may be considered to augment wound healing or ameliorate ischemic rest pain in CLTI patients for whom revascularization is not an option (Grade 2B).

Consider when revascularization is not feasible.

Venous leg ulcers / CVI with edema or lymphedema: ESVS (2022) and randomized trials (Alvarez 2020; Lurie 2017) support considering IPC as an adjunct when other compression options are unavailable, cannot be used, or have failed; trials report faster median time to wound closure and reduced pain in selected patients.

ESVS recommendation: consider IPC when other options not feasible (Grade 2A).

DVT prophylaxis in immobile post-stroke patients: CLOTS 3 and supporting analyses show IPC reduces DVT incidence and may improve survival in immobile post-stroke patients compared with no IPC.

Trials used IPC until walking independently or up to 30 days with CDU screening at 7-10 and 25-30 days.

inv-05: Clinical coverage considerations

Coverage considerations align with guideline recommendations and clinical trial evidence; use mechanical prophylaxis especially when pharmacologic prophylaxis is contraindicated or in combination for high-risk patients.

Use of IPC in postoperative immobilized outpatients: Domeij-Arverud RCT: IPC for 6 hours/day for 2 weeks reduced 2-week DVT incidence (21% vs 37%, p=0.042); effect did not persist at 6 weeks after stopping IPC.2-week assessment

Supports short-term IPC to reduce early postoperative DVT in immobilized outpatients.

When to prefer mechanical prophylaxis: ASH (2019) conditional recommendations: favor mechanical methods over pharmacologic when bleeding risk is high; use mechanical prophylaxis over no prophylaxis when pharmacologic prophylaxis not given; prefer IPC over graduated compression stockings when mechanical prophylaxis is used.

Conditional recommendations based on low/very low certainty evidence.

Combined prophylaxis: Guidelines (ASH, European) suggest combined mechanical and pharmacological prophylaxis may further reduce VTE in high-risk patients; consider IPC plus pharmacologic prophylaxis in very high-risk patients.

Advanced intermittent pneumatic compression devices (APCDs) marketed for treatment of lymphedema of the head, face, or neck are considered unproven and not medically necessary for these anatomic indications; this policy explicitly states APCDs (e.g., Flexitouch) for head/face/neck lymphedema are unproven and not medically necessary.

Examples of trial exclusions and contraindications used in CLOTS 3 include: dermatitis, leg ulcers, severe edema, severe peripheral vascular disease, and congestive cardiac failure; these conditions were grounds for excluding patients from IPC in that trial.

Mechanical prophylaxis (including IPC/PCDs) should not be used in patients with suspected or proven peripheral arterial disease (PAD), in patients with recent peripheral arterial bypass grafting, in those with peripheral neuropathy or other sensory impairment, or when local conditions (fragile skin, dermatitis, gangrene, recent skin graft), severe leg edema, or major limb deformity prevent a correct fit.

The policy explicitly labels as unproven and not medically necessary both: (1) APCDs for lymphedema of the head, face, or neck (advanced devices such as Flexitouch) and (2) high‑pressure, rapid inflation/deflation pneumatic compression devices for peripheral arterial disease (PAD).

A large randomized trial (Arabi et al.) found that adding IPC to routine pharmacologic thromboprophylaxis in critically ill patients did not reduce proximal lower‑limb DVT compared with pharmacologic prophylaxis alone; the trial reported similar proximal DVT incidence and no mortality benefit, supporting that routine adjunctive IPC in these patients provided no additional proximal DVT prevention.

Guideline reviews and meta-analyses indicate that mechanical prophylaxis alone is not supported as sufficient in many settings; most evidence does not support mechanical prophylaxis by itself, and pharmacologic prophylaxis or combined approaches are generally preferred when not contraindicated.

Medical Necessity Scenarios

inv-34: DME medical necessity scenarios — clinical scenarios supported by evidence and referenced InterQual criteria

Clinical scenarios supported by evidence and referenced InterQual criteria:

Supported uses: IPC for DVT prevention in certain circumstances; pneumatic compression devices as adjunct for lymphedema or CVI with edema and non-healing lower extremity ulcers when InterQual criteria are met; IPC may aid healing of venous ulcers when added to standard compression.

See InterQual for specific clinical criteria and patient eligibility.

inv-35: DME medical necessity contexts — contexts where IPC has demonstrated benefit or is recommended by guidelines

Contexts where IPC has demonstrated benefit or is recommended by guidelines:

Immobile post-stroke patients: IPC reduces DVT incidence and may improve survival compared with no IPC in immobile post-stroke patients (CLOTS 3 and supporting analyses).

Used until walking independently or up to 30 days in trials; CDU screening at 7-10 and 25-30 days.

Coding (HCPCS)

Applicable HCPCS Codes (selection)HCPCS

A4600	Sleeve for intermittent limb compression device, replacement only, each.
E0650	Pneumatic compressor, nonsegmental home model.
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure

Applicable HCPCS Codes (continued)HCPCS

E0652	Pneumatic compressor, segmental home model with calibrated gradient pressure.
E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm.
E0658	Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest.
E0659	Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg.
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm.
E0666	Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg.
E0667	Segmental pneumatic appliance for use with pneumatic compressor, full leg.
E0668	Segmental pneumatic appliance for use with pneumatic compressor, full arm.
E0669	Segmental pneumatic appliance for use with pneumatic compressor, half leg.

1–10 of 16

1/2

Applicable HCPCS codes (updated)HCPCS

E0658	HCPCS code added (description not provided in this chunk)
E0659	HCPCS code added (description not provided in this chunk)

inv-15: Study follow-up timing — assess DVT at 2 weeks and 6 weeks

Follow-up timepointsAssess for DVT with duplex compression ultrasound at 2 weeks and again at 6 weeks (trial schedules: 2-week assessment while on IPC; 6-week assessment four weeks after IPC stopped).

2-week outcome relevanceEarly benefit: Domeij-Arverud RCT showed reduced DVT incidence at 2 weeks (21% vs 37%, p=0.042) when IPC used 6 hours/day for 2 weeks.

6-week outcome relevanceEffect may not persist: At 6 weeks (4 weeks after stopping IPC) DVT incidence converged (52% vs 48%, not significant).

Provider Actions and Prior Authorization

Prior Authorization

Prior authorization: verify indication and contraindications

Prior authorization required. Verify the clinical indication and ensure there are no contraindications before submitting for prior authorization.

Prior authorization must confirm the device is requested for a covered indication (e.g., lymphedema, chronic venous insufficiency with edema and non-healing lower extremity ulcers, or DVT prevention per InterQual criteria).
Document absence of contraindications such as dermatitis at the application site, active leg ulcers when device intended for contraindicated use, severe peripheral arterial disease, congestive heart failure when noted as exclusion, or other clinical exclusions noted in CLOTS 3 and InterQual.

Step Therapy

Step before advanced IPC for venous disease — attempt standard compression first

Step-therapy expectation for venous disease: attempt standard compression therapies before advanced IPC when clinically appropriate.

Rental and Purchase Rules

HCPCS Code	Description	Notes
A4600
Sleeve for intermittent limb compression device, replacement only, each.
Listed in Applicable Codes; replacement sleeve code referenced for replacement items.

Evidence topic	Key findings	Implication for rental vs purchase
IPC efficacy in surgical/orthopedic patients
Systematic reviews and RCTs (e.g., Hayes assessment, Pavon et al.) show IPC may reduce DVT incidence, particularly when combined with pharmacologic prophylaxis; evidence for IPC alone is mixed.
Studies evaluated device clinical effectiveness, not procurement models; policy does not specify rental vs purchase rules.

Policy history item	Effect on HCPCS coding	Relevance to rental/purchase billing
11/01/2025 coding update
Updated list of applicable HCPCS codes to reflect quarterly edits; added E0658 and E0659.
Code additions may affect claim coding and billing for devices (rental vs purchase) but the policy text does not provide explicit rules on rental versus purchase determinations.

Replacement and Accessories

inv-40: Replacement sleeves (A4600) — replacement code reference

HCPCS codeA4600 — Sleeve for intermittent limb compression device, replacement only, each.

PurposeReplacement sleeves billed with A4600 are for replacement only (not initial appliance).

Documentation noteListing of the code in the policy is for reference; inclusion does not guarantee coverage — check federal/state/contractual requirements.

inv-41: IPC devices — replacement-related key values

Replacement considerationIPC device garments and appliances (E06xx group) are identified in the policy for coding and replacement considerations.

Example codesPolicy lists multiple appliance codes (E0655, E0660, E0665, etc.) for pneumatic appliances — replacement of garments may require appropriate HCPCS appliance code on claim.

Documentation Requirements

Billing Rule

Reference HCPCS codes and check state Medicaid fee schedule

When requesting authorization, reference the appropriate HCPCS codes and check the State Medicaid fee schedule (codes with an asterisk in the policy may not be covered by Louisiana Medicaid).

Include the exact HCPCS code(s) on the authorization request.
Confirm Medicaid coverage status for codes marked with an asterisk.

Documentation Required

Document mobility status and contraindications; include duplex ultrasound when available

Document the patient’s mobility status and any contraindications to IPC; trials used duplex ultrasound (CDU) at prespecified intervals to assess outcomes, and those assessments should be included when available.

Record immobility criteria consistent with trial definitions if claiming DVT prevention.

Not Covered / Exclusions

NOT COVERED: Advanced pneumatic compression devices for head/face/neck lymphedema and high‑pressure rapid‑inflation PCDs for PAD are considered unproven and not medically necessary and therefore are not eligible for coverage under this policy.

NOT COVERED: Routine use of adjunctive IPC added to pharmacologic thromboprophylaxis in critically ill patients is considered not supported by evidence in this context — a large RCT showed no reduction in proximal lower‑limb DVT when IPC was added to pharmacologic prophylaxis.

NOT COVERED: Mechanical prophylaxis devices are not appropriate for patients with peripheral arterial disease, recent peripheral arterial bypass grafting, sensory impairment that prevents detection of injury, fragile or damaged local skin, severe leg edema, or major limb deformity that prevents correct fit; additionally, most evidence does not support mechanical prophylaxis as sole therapy where pharmacologic prophylaxis is appropriate.

Background

Pneumatic compression devices (PCDs) apply cyclical/sequential pressure through garments to the limb or target region to reduce edema, augment venous return, and stimulate lymphatic flow and fibrinolytic activity; devices range from simple intermittent pneumatic compression (IPC) sleeves to more complex, programmable advanced pneumatic compression devices (APCDs) designed for anatomically specialized areas such as the head and neck.

Definitions

inv-29: IPC definition — Intermittent pneumatic compression (IPC)

DefinitionIntermittent pneumatic compression (IPC) — inflatable sleeves wrapped around the limb that sequentially inflate and deflate to compress the limb at intervals.

MechanismInflation may be sequential (distal then proximal) to increase venous flow, reducing venous stasis and stimulating intrinsic fibrinolytic factors.

Common usesUsed for DVT prevention and to reduce edema; sleeves can be applied to calf or calf + thigh configurations.

inv-30: APCD definition — Advanced pneumatic compression devices (APCDs)

DefinitionAdvanced pneumatic compression devices (APCDs) — more complex, programmable systems with multiple garment options intended to address fibrosis, head/face/neck or trunk edema, chronic wounds, or localized swelling.

Revision History

2025-11-01coding_updateLatest

Updated list of applicable HCPCS codes to reflect quarterly edits; added E0658 and E0659.

2025-11-01archival

Archived previous policy version CS097LA.P.

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices (for Louisiana Only)

Policy CodePolicy CS097LA.Q

Change TypeCoding update — HCPCS list amended

Effective DateNov 1, 2025

Next Review Date

Key ActionUse the updated HCPCS code list (including newly added E0658 and E0659) when submitting prior authorization requests and claims.

SourceLink

On This Page

DVT prophylaxis in surgical / orthopedic populations: Systematic reviews and RCTs present mixed results; IPC may reduce DVT incidence particularly when combined with pharmacologic prophylaxis, while IPC alone is often less effective than LMWH alone for some surgeries.

Cochrane and surgical meta-analyses report variable effects by procedure and prophylaxis strategy.

Critically ill patients receiving pharmacologic prophylaxis: A large RCT (Arabi et al.) found no benefit of adjunctive IPC added to pharmacologic thromboprophylaxis in critically ill patients for proximal lower-limb DVT prevention.

Adjunctive IPC may not provide additional DVT prevention in these settings.

Patients at high bleeding risk: ASH guidance suggests mechanical prophylaxis (including IPC) over pharmacologic methods for patients at high bleeding risk and suggests using mechanical prophylaxis over no prophylaxis when pharmacologic prophylaxis is not given.

Conditional recommendations based on low/moderate certainty evidence.

European guidance grades vary (e.g., Grade 1C/2C/2B).

Contraindications / do not use: NICE advises mechanical prophylaxis should not be used in patients with peripheral arterial disease, peripheral arterial bypass grafting, peripheral neuropathy with sensory impairment, local conditions at risk of damage (fragile skin, dermatitis, gangrene, recent skin graft), severe leg edema, or major limb deformity preventing correct fit.

Explicit patient safety exclusions for mechanical devices.

Patients with venous leg ulcers / CVD with edema not controlled by standard compression: IPC considered as adjunct when standard compression modalities are unavailable or have failed; trials (Alvarez 2020, Lurie 2017) show improved wound healing metrics in select populations.

ESVS Grade 2A recommendation to consider IPC when other options not feasible.

Patients at high bleeding risk or contraindicated for pharmacologic prophylaxis: Guidelines (ASH, European) suggest mechanical prophylaxis including IPC over no prophylaxis for patients who cannot receive pharmacologic agents; IPC is reasonable when pharmacologic prophylaxis is contraindicated.

Conditional recommendation.

inv-36: DME medical necessity criteria — specific clinical criteria where IPC may be medically necessary

Clinical scenarios where IPC may be medically necessary based on evidence and guideline recommendations.

Early postoperative immobilized outpatients: IPC may be considered to reduce early DVT risk during periods of immobilization (e.g., postoperative Achilles tendon repair) as RCT evidence shows reduced 2-week DVT incidence.2 weeks of use described in trial

Benefit may not persist after stopping therapy.

Patients with high bleeding risk: When pharmacologic prophylaxis is contraindicated due to bleeding risk, IPC is suggested over no prophylaxis (per ASH and European guidance).

Used as an alternative to pharmacologic agents.

Very high VTE risk: Consider combined pharmacologic and mechanical prophylaxis (IPC) in patients at very high risk of VTE to further reduce DVT incidence (per guidelines).

Guidelines vary in grade strength; apply clinical judgment.

Trial of standard compression (elastic compression stockings, multilayer bandaging, adjustable compression garments, or inelastic bandages) should be documented and attempted unless clinically contraindicated or not feasible.
IPC may be considered when other compression options are not available, cannot be used, or have failed to promote ulcer healing.
Document duration and response to prior compression trials in the medical record.
When IPC is requested as prevention of DVT (eg, post-stroke immobile patients), document immobility status consistent with CLOTS 3 criteria (unable to get up from chair/out of bed and walk to toilet without help).

Billing Rule

Use current HCPCS codes for prior authorization

Use current HCPCS codes when requesting prior authorization and submitting claims; codes listed in this policy are for reference only and inclusion does not guarantee coverage.

Ensure authorization and claims use the latest HCPCS codes (including newly added E0658 and E0659).
Codes in this policy (e.g., E0650–E0676, A4600) may be updated quarterly — validate code status against current payer and state fee schedules before submission.
Codes marked with an asterisk in the Applicable Codes list may not be covered by specific state programs (e.g., Louisiana Medicaid).

Billing Rule

Coding and claim submission risk

Coding and claim submission risk: failure to use current HCPCS codes or to indicate medical necessity per plan/contract requirements may result in claim denial or delayed payment.

Verify the most recent code edits and implement E0658 and E0659 where appropriate.
Include supporting documentation to justify code selection (eg, device model, segmental vs nonsegmental appliance, body region treated).
Be aware that some HCPCS codes (marked *) are not on certain state Medicaid fee schedules and may be denied for those members.

Documentation Required

Coding and documentation note

Coding and documentation note: lists of codes are provided for reference and do not imply coverage. Thorough documentation of medical necessity is required with the prior authorization request and on claims.

Provide clinical notes that specify diagnosis, laterality/body region, prior conservative therapy, and reason for IPC use.
Specify the HCPCS code with appliance description (segmental vs nonsegmental, full arm/leg/head/neck/chest) and include device/garment documentation.
Inclusion of a code in this policy does not guarantee reimbursement — adjudication follows federal/state/contractual plan terms.

Documentation Required